Similarly, the quantitative measurement of low levels of HER2 may be clinically relevant for other types of solid tumors as in the case of Barrett's esophagus-associated adenocarcinoma cancer [35]. The gene discussed is ERBB2; the disease is esophageal adenocarcinoma.